Company intelligence / Profile preview

ANRI

Ownership: Private
Development stage: Other

Overview

ANRI is a Tokyo-based venture capital firm founded in 2012. It specializes in seed and early-stage investments across diverse sectors including technology, healthcare, biotechnology, and medical startups. While it invests in the life sciences sector and has backed companies developing advanced therapeutics and technologies, it does not itself develop drugs or maintain a clinical pipeline[1][2][3].

Industry: Investors

Partnerships

As an investor, partners with portfolio companies rather than forming traditional pharma partnerships. Notable investment: Strand Therapeutics (mRNA therapies for cancer)[7].

Beyond the preview

Go deeper on ANRI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANRI.

Explore the full profile